Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.33M Sell
5,905
-61
-1% -$13.3K 0.56% 51
2025
Q3
$1.13M Sell
5,966
-58
-1% -$10.5K 0.48% 57
2025
Q2
$949K Buy
6,024
+703
+13% +$106K 0.42% 64
2025
Q1
$938K Buy
5,321
+609
+13% +$118K 0.46% 64
2024
Q4
$926K Sell
4,712
-691
-13% -$146K 0.48% 62
2024
Q3
$1.28M Buy
5,403
+551
+11% +$130K 0.67% 48
2024
Q2
$1.03M Buy
4,852
+407
+9% +$92.5K 0.59% 46
2024
Q1
$1.12M Sell
4,445
-12
-0.3% -$2.8K 0.68% 45
2023
Q4
$1.03M Buy
4,457
+286
+7% +$58.7K 0.72% 40
2023
Q3
$821K Buy
4,171
+813
+24% +$177K 0.65% 39
2023
Q2
$755K Buy
3,358
+79
+2% +$15.9K 0.57% 46
2023
Q1
$652K Buy
3,279
+311
+10% +$66.5K 0.48% 49
2022
Q4
$608K Buy
2,968
+281
+10% +$57K 0.47% 47
2022
Q3
$487K Buy
2,687
+84
+3% +$18.4K 0.44% 47
2022
Q2
$565K Buy
2,603
+144
+6% +$31.3K 0.49% 41
2022
Q1
$569K Buy
2,459
+101
+4% +$23.9K 0.44% 45
2021
Q4
$663K Buy
+2,358
New +$612K 0.51% 37

Other funds holding IQV

Bowman & Company's IQV Position: Q4 2025 in Review

Bowman & Company reduced its IQVIA (IQV) stake by 1% in Q4 2025, selling an estimated $13.3K and leaving 5,905 shares worth $1.33M. The position accounts for 0.56% of the portfolio, ranked #51.

Bowman & Company first reported a position in IQV in Q4 2021 and has held it in 17 quarters since. 1,144 funds tracked by Wall St. Rank hold IQV as of Q4 2025.

  • Bowman & Company held 5,905 shares of IQVIA worth $1.33M as of Q4 2025.
  • Bowman & Company sold 61 IQVIA shares in Q4 2025, an estimated $13.3K.
  • IQVIA made up 0.56% of Bowman & Company's portfolio in Q4 2025, its #51 holding.
  • Bowman & Company first reported a position in IQVIA in Q4 2021 and has held it in 17 quarters since.
  • 1,144 funds tracked by Wall St. Rank held IQVIA as of Q4 2025.

Based on Bowman & Company's 13F filing for Q4 2025, filed 23 Jan 2026.